Bad Blood: Secrets and Lies in a Silicon Valley Startup/

In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry w

In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood.Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.5 billion.There was just one problem: The technology didn't work.Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments.All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings-from journalists to their own employees.Rigorously reported and fearlessly written, Bad Blood is a gripping story of the biggest corporate fraud since Enron-a tale of ambition and hubris set amid the bold promises of Silicon Valley.